Dexcom Announces Upcoming Conference Presentation
August 03 2022 - 4:15PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain,
Executive Vice President and Chief Financial Officer, will present
an update on the company at the Canaccord Genuity 42nd Annual
Growth Conference on Wednesday, August 10, 2022 at 10:30am
(EST).
Links to the webcasts will be available on the Dexcom Investor
Relations website at investors.dexcom.com and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through
innovative continuous glucose monitoring (CGM) products.
Headquartered in San Diego, California, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
patients, caregivers, and clinicians, Dexcom simplifies and
improves diabetes management around the world.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220803005958/en/
DexCom, Inc. Sean Christensen Senior Director – Investor
Relations and Corporate FP&A investor-relations@dexcom.com
(858) 200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Sep 2024 to Oct 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Oct 2023 to Oct 2024